Genetics and epigenetics of 1q rearrangements in hematological malignancies.
Recently, we and others have described a novel class of chromosome aberrations that involves constitutive heterochromatin on human chromosome 1 (cytogenetic band 1q12). These anomalies are particularly frequent in B cell non-Hodgkins lymphoma (NHL) and multiple myeloma (MM) and, remarkably, almost invariably involve partial or total gain of chromosome 1q (including 1q12 heterochromatin) and the formation of novel heterochromatin/euchromatin junctions. This review discusses the pathological significance of these anomalies in light of i) recent integrated gene expression and array comparative genomic hybridisation (aCGH) profiling in MM and ii) increasing evidence of a key role for heterochromatin in the control of normal and pathological gene silencing.
Fournier
A
A
Equipe Oncogenic pathways in the hematological malignancies, INSERM/UJF Research Centre U823, Institut Albert Bonniot - UJF Pôle Santé, BP 170, Grenoble, France.
Florin
A
A
Lefebvre
C
C
Solly
F
F
Leroux
D
D
Callanan
M B
MB
D002878:Chromosomes, Human, Pair 1; D044127:Epigenesis, Genetic; D019337:Hematologic Neoplasms / Q000235:genetics*; D006570:Heterochromatin / Q000502:physiology; D006801:Humans; D009693:Nucleic Acid Hybridization
D006570:Heterochromatin